23andMe petitions Fed Circuit for en banc review
DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
US government sues Gilead for patent infringement over HIV drugs
The US government is suing Gilead for patent infringement, claiming that the pharmaceutical company has been piggybacking on public research to earn billions from its HIV drugs.
Second Circuit dismisses antitrust claims against Roche
The US Court of Appeals for the Second Circuit has dismissed a Russian pharmaceutical company’s antitrust claims against Roche.
Pfizer and Sun settle Bosulif dispute
Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.
Takeda sells generics portfolio to Stada for $660m
German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.
USITC begins Olympus patent probe
The US International Trade Commission is investigating certain endoscopic devices after a German medical devices company accused Japanese optical products manufacturer Olympus of patent infringement.
Donald Trump to nominate Stephen Hahn as FDA commissioner
US President Donald Trump has nominated a new commissioner of the Food and Drug Administration.
Counterfeit fentanyl dealer jailed for 30 years
An individual who manufactured and sold counterfeit fentanyl has been sentenced to 30 years in prison by a US court.
Latham and Watkins promote three
Latham and Watkins has unveiled two new IP partners and one counsel as part of its annual appointments and promotions.
EPO Board of Appeal issues communication on BI CRISPR/Cas9 patent hearing
The Board of Appeal of the European Patent Office has issued new communication summarising issues that will be discussed at a hearing on whether the EPO erred in its revocation of a patent owned by the Broad Institute.
